Sign inGet started

Myers Diane

Insider CIK 1602335 · REPH Senior VP-Reg/Quality, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
REPH Recro Pharma, Inc. M Exercise deriv2018-01-182018-01-222,500— $07,500SEC↗
REPH Recro Pharma, Inc. F Tax w/h2018-01-182018-01-22775$8.89 $6.9K18,528SEC↗
REPH Recro Pharma, Inc. M Exercise2018-01-182018-01-222,500— $019,303SEC↗
REPH Recro Pharma, Inc. A Award deriv2018-01-022018-01-0416,000— $016,000SEC↗
REPH Recro Pharma, Inc. A Award2018-01-022018-01-048,000— $016,803SEC↗
REPH Recro Pharma, Inc. M Exercise2017-09-282017-10-028,000— $011,283SEC↗
REPH Recro Pharma, Inc. F Tax w/h2017-09-282017-10-022,480$9.04 $22.4K8,803SEC↗
REPH Recro Pharma, Inc. A Award deriv2017-01-182017-01-2010,000— $010,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2017-01-182017-01-2015,000— $015,000SEC↗
REPH Recro Pharma, Inc. F Tax w/h2016-12-012016-12-05777$6.48 $5.0K3,283SEC↗
REPH Recro Pharma, Inc. M Exercise2016-12-012016-12-052,500— $04,060SEC↗
REPH Recro Pharma, Inc. M Exercise2016-08-012016-08-032,500— $02,500SEC↗
REPH Recro Pharma, Inc. F Tax w/h2016-08-012016-08-03940$9.70 $9.1K1,560SEC↗
REPH Recro Pharma, Inc. A Award deriv2015-12-162015-12-1818,000— $018,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2015-07-252015-07-2818,000— $018,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-12-172015-07-2818,000— $018,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-12-172014-12-1918,000— $018,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-12-172014-12-1918,000— $018,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-04-082014-04-0910,000— $010,000SEC↗
REPH Recro Pharma, Inc. A Award deriv2014-03-122014-03-1312,000— $012,000SEC↗